secwatch.observer — SEC 8-K summary
======================================

Issuer:     10x Genomics, Inc. (TXG)
CIK:        0001770787
Form:       8-K
Filed at:   2025-11-14T23:59:59+00:00
Accession:  0001628280-25-052154
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

10x Genomics CLO Eric Whitaker retiring Jan 1, 2026; Randy Wu named General Counsel
--------------------------------------------------------------------------------

- Eric Whitaker to retire as Chief Legal Officer effective Jan 1, 2026, will remain as Strategic Counsel with reduced compensation.
- Dr. Randy Wu, VP of IP and Litigation, appointed General Counsel and Secretary effective Jan 1, 2026.
- Wu joined 10x in August 2016; holds Ph.D. in Biophysics from UCSF and J.D. from Stanford Law School.
- CEO Serge Saxonov praised Whitaker's eight-year tenure including IPO and legal strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1770787/000162828025052154/0001628280-25-052154-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1770787/000162828025052154/txg-20251112.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-052154

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer